Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Bio-Rad Laboratories, Inc. (BIO) - Product Pipeline Analysis Brochure
Document related concepts
no text concepts found
Transcript
Brochure More information from http://www.researchandmarkets.com/reports/1945435/ Bio-Rad Laboratories, Inc. (BIO) - Product Pipeline Analysis Description: Summary Bio-Rad Laboratories, Inc. (Bio-Rad) is engaged in the development and manufacture of specialty chemicals for use in biochemical, pharmaceutical and other life science research applications. The company supplies a wide range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components to the life science research, healthcare, analytical chemistry and other markets. Through its global network of operations, the company serves more than 100,000 research and industry customers around the world. The company operates in more than 35 countries in North America, Europe, Asia, Middle East and Africa. Bio-Rad is headquartered in California, the US. The company's strategy is to grow by acquisitions and investments. It focuses on research and development in order to achieve product development. In line with its strategy in October 2011, Bio-Rad purchased QuantaLife, Inc. for $162m. This report is a source for data, analysis and actionable intelligence on the Bio-Rad Laboratories, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons to Buy - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally. - Design and develop your product development, marketing and sales strategies. - Exploit M&A opportunities by identifying market players with the most innovative pipeline. - Develop market-entry and market expansion strategies. - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return. - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next highvalue products that your competitor would add in its portfolio? – identify, understand and capitalize. Contents: List of Tables List of Figures Bio-Rad Laboratories, Inc. - Business Description Key Facts Bio-Rad Laboratories, Inc. - Major Products and Services Bio-Rad Laboratories, Inc. Pipeline Products by Equipment Type Bio-Rad Laboratories, Inc. Pipeline Products by Development Stage Bio-Rad Laboratories, Inc. Pipeline Products by Therapy Area BioPlex 2200 - Cardiac Disease BioPlex 2200 - Cardiac Disease Product Status BioPlex 2200 - Cardiac Disease Product Description BioPlex 2200 - Cardiac Disease Product Patent Details BioPlex 2200 - Celiac Disease IgA tTG Assay BioPlex 2200 - Celiac Disease IgA tTG Assay Product Status BioPlex 2200 - Celiac Disease IgA tTG Assay Product Description BioPlex 2200 - Celiac Disease IgA tTG Assay Product Patent Details BioPlex 2200 - Celiac Disease IgG tTG Assay BioPlex 2200 - Celiac Disease IgG tTG Assay Product Status BioPlex 2200 - Celiac Disease IgG tTG Assay Product Description BioPlex 2200 - Celiac Disease IgG tTG Assay Product Patent Details BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay Product Status BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay Product Description BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay Product Patent Details BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay Product Status BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay Product Description BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay Product Patent Details BioPlex 2200 - Diabetes BioPlex 2200 - Diabetes Product Status BioPlex 2200 - Diabetes Product Description BioPlex 2200 - Gastrointestinal Disease Test BioPlex 2200 - Gastrointestinal Disease Test Product Status BioPlex 2200 - Gastrointestinal Disease Test Product Description BioPlex 2200 - Hepatitis Test BioPlex 2200 - Hepatitis Test Product Status BioPlex 2200 - Hepatitis Test Product Description BioPlex 2200 - HIV Test BioPlex 2200 - HIV Test Product Status BioPlex 2200 - HIV Test Product Description BioPlex 2200 - HIV/Hep Screening BioPlex 2200 - HIV/Hep Screening Product Status BioPlex 2200 - HIV/Hep Screening Product Description BioPlex 2200 - Lyme IgG Test BioPlex 2200 - Lyme IgG Test Product Status BioPlex 2200 - Lyme IgG Test Product Description BioPlex 2200 - Lyme IgM Assay BioPlex 2200 - Lyme IgM Assay Product Status BioPlex 2200 - Lyme IgM Assay Product Description BioPlex 2200 - Vitamin D Test BioPlex 2200 - Vitamin D Test Product Status BioPlex 2200 - Vitamin D Test Product Description EVOLIS - Autoimmune Panel EVOLIS - Autoimmune Panel Product Status EVOLIS - Autoimmune Panel Product Description EVOLIS - Infectious Disease Test EVOLIS - Infectious Disease Test Product Status EVOLIS - Infectious Disease Test Product Description Platelia Dengue NS1 Ag Microplate Assay Platelia Dengue NS1 Ag Microplate Assay Product Status Platelia Dengue NS1 Ag Microplate Assay Product Description Bio-Rad Laboratories, Inc. - Key Competitors Bio-Rad Laboratories, Inc. - Key Employees Bio-Rad Laboratories, Inc. - Key Employee Biographies Bio-Rad Laboratories, Inc. - Locations And Subsidiaries Head Office Other Locations & Subsidiaries Recent Developments Bio-Rad Laboratories, Inc., Recent Developments Nov 06, 2012: Bio-Rad Reports Revenue Of $498.7m In Q3 2012 Aug 29, 2012: Bio-Rad Opens Digital Biology Center To Develop Products For R&D Markets Based On Its Droplet Digital Technology Aug 07, 2012: Bio-Rad Reports Revenue Of $510.4m In Q2 2012 May 02, 2012: Bio-Rad Reports Revenue Of $486.3m In Q1 2012 Apr 30, 2012: Vermillion Resolves Non-Contingent Claims With Bio-Rad Feb 23, 2012: Bio-Rad Reports Revenue Of $2.1 Billion In 2011 Nov 01, 2011: Bio-Rad Appoints Deborah J Neff To Board Nov 01, 2011: Bio-Rad Reports Revenues Of $516.5m In Q3 2011 Aug 13, 2011: GE Healthcare And Bio-Rad Reach Settlement In Label-Free Detection Lawsuit Aug 02, 2011: Bio-Rad Reports Revenue Of $521.7m In Q2 2011 Appendix Methodology About Us Contact Us Disclaimer List of Tables Bio-Rad Laboratories, Inc., Key Facts Bio-Rad Laboratories, Inc. Key Pipeline Products by Equipment Type Bio-Rad Laboratories, Inc. Key Pipeline Products by Therapy Area Bio-Rad Laboratories, Inc. Key Pipeline Products by Development Stage Bio-Rad Laboratories, Inc., Key Facts Bio-Rad Laboratories, Inc., Major Products and Services Bio-Rad Laboratories, Inc. Number of Pipeline Products by Equipment Type Bio-Rad Laboratories, Inc. Pipeline Products by Equipment Type Bio-Rad Laboratories, Inc. Number of Pipeline Products by Development Stage Bio-Rad Laboratories, Inc. Pipeline Products by Development Stage Bio-Rad Laboratories, Inc. Number of Pipeline Products by Therapy Area Bio-Rad Laboratories, Inc. Pipeline Products by Therapy Area BioPlex 2200 - Cardiac Disease - Product Status BioPlex 2200 - Cardiac Disease - Product Description BioPlex 2200 - Cardiac Disease - Patent Details1 BioPlex 2200 - Celiac Disease IgA tTG Assay - Product Status BioPlex 2200 - Celiac Disease IgA tTG Assay - Product Description BioPlex 2200 - Celiac Disease IgA tTG Assay - Patent Details1 BioPlex 2200 - Celiac Disease IgG tTG Assay - Product Status BioPlex 2200 - Celiac Disease IgG tTG Assay - Product Description BioPlex 2200 - Celiac Disease IgG tTG Assay - Patent Details1 BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay - Product Status BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay - Product Description BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay - Patent Details1 BioPlex 2200 - Deamidated Gliadin Celiac IgA Assay - Patent Details2 BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay - Product Status BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay - Product Description BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay - Patent Details1 BioPlex 2200 - Deamidated Gliadin Celiac IgG Assay - Patent Details2 BioPlex 2200 - Diabetes - Product Status BioPlex 2200 - Diabetes - Product Description BioPlex 2200 - Gastrointestinal Disease Test - Product Status BioPlex 2200 - Gastrointestinal Disease Test - Product Description BioPlex 2200 - Hepatitis Test - Product Status BioPlex 2200 - Hepatitis Test - Product Description BioPlex 2200 - HIV Test - Product Status BioPlex 2200 - HIV Test - Product Description BioPlex 2200 - HIV/Hep Screening - Product Status BioPlex 2200 - HIV/Hep Screening - Product Description BioPlex 2200 - Lyme IgG Test - Product Status BioPlex 2200 - Lyme IgG Test - Product Description BioPlex 2200 - Lyme IgM Assay - Product Status BioPlex 2200 - Lyme IgM Assay - Product Description BioPlex 2200 - Vitamin D Test - Product Status BioPlex 2200 - Vitamin D Test - Product Description EVOLIS - Autoimmune Panel - Product Status EVOLIS - Autoimmune Panel - Product Description EVOLIS - Infectious Disease Test - Product Status EVOLIS - Infectious Disease Test - Product Description Platelia Dengue NS1 Ag Microplate Assay - Product Status Platelia Dengue NS1 Ag Microplate Assay - Product Description Bio-Rad Laboratories, Inc., Key Employees Bio-Rad Laboratories, Inc., Key Employee Biographies Bio-Rad Laboratories, Inc., Other Locations Bio-Rad Laboratories, Inc., Subsidiaries List of Figures Bio-Rad Laboratories, Inc. Pipeline Products by Equipment Type Bio-Rad Laboratories, Inc. Pipeline Products by Development Stage Bio-Rad Laboratories, Inc. Pipeline Products by Therapy Area Ordering: Order Online - http://www.researchandmarkets.com/reports/1945435/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/ Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Bio-Rad Laboratories, Inc. (BIO) - Product Pipeline Analysis Web Address: http://www.researchandmarkets.com/reports/1945435/ Office Code: SCHL3FA7 Product Formats Please select the product formats and quantity you require: Quantity Electronic (PDF) Single User: USD 750 Electronic (PDF) Site License: USD 1500 Electronic (PDF) Enterprisewide: USD 2250 Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name: Mr Mrs Dr Miss Last Name: Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL) Ms Prof Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an email with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number 833 130 83 Sort code 98-53-30 Swift code ULSBIE2D IBAN number IE78ULSB98533083313083 Bank Address Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World
